Executive Summary
This digest covers 15 filings from July 13, 2026, tracking M&A and sector consolidation across Indian markets. The most significant development is Grasim Industries' subsidiary acquiring a 5.0 GWp renewable energy portfolio for INR 17,200 crore, signaling a major push into green energy by the Aditya Birla Group.
Tata Capital's entry into the gold loan segment via an 88.6% stake in Yogakshemam Loans (AUM ₹708 crore) highlights NBFC consolidation in high-growth retail lending. The healthcare sector sees completion of the Aster DM-Quality Care amalgamation, creating a larger hospital chain. A notable trend is the shift toward manufacturing and 'Make in India' plays, as seen in Creative Newtech's acquisition of Infinova's surveillance tech facility and Somany Ceramics' investments in new ceramic and construction chemicals ventures. However, several deals involve pre-revenue or thinly profitable targets (Gennova's PAT margin ~1.1%, Siravit Ceramics with nil turnover), indicating higher execution risk. Overall, the period shows robust corporate activity with a focus on vertical integration, geographic expansion, and entry into adjacent high-growth segments.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: M&A
Tracking the trend? Catch up on the prior India Sector Consolidation Regulatory Filings digest from July 06, 2026.
Investment Signals (10)
- Grasim Industries ↓ (BULLISH)▲
Subsidiary ABReN acquiring 5.0 GWp renewable portfolio (3.3 GWp operational) at INR 17,200 crore EV; SPPL's FY25 turnover grew 8.2% YoY to INR 1,253.4 crore, with 0.1% growth in FY24 indicating a recent acceleration. The deal accelerates ABReN's total portfolio to ~9.4 GWp, creating a top-tier Indian renewable player.
- Tata Capital ↓ (BULLISH)▲
Acquiring 88.6% of Yogakshemam Loans (AUM ₹708 crore, 162 branches, ~32,000 customers) for pre-money valuation ≤₹318 crore; entry into gold loans diversifies retail lending. Yogloans' FY26 PAT of ₹14.21 crore on turnover ₹140.39 crore implies ~10% PAT margin. TCL's AAA rating provides funding advantage.
- Aster DM Healthcare ↓ (BULLISH)▲
Completion of Quality Care India amalgamation (share ratio 977:1000) increases issued capital from 51.8 crore to 87.2 crore shares, creating a larger hospital platform. No insider selling reported, suggesting management confidence in post-merger synergies.
- Creative Newtech ↓ (BULLISH)▲
Acquiring 100% of Infinova India for up to USD 4M, gaining exclusive brand rights, Pune manufacturing facility, and experienced team. This supports strategic shift from distribution to integrated surveillance tech platform under Make in India.
- Somany Ceramics ↓ (MIXED)▲
Investing ₹58.80 crore for 49% in Siravit Ceramics (pre-revenue glazed vitrified tiles for Southern market) and ₹2 crore for 50% in V.S. Industries (Nepal construction chemicals JV). While pre-revenue carries risk, the strategic expansion into new geographies and product lines is a long-term positive.
- Emcure Pharmaceuticals ↓ (BEARISH)▲
Acquiring remaining 12.05% of Gennova for ₹231.87 crore (valuing 100% at ~₹1,924 crore). Gennova's FY26 PAT margin was only ~1.1% on turnover ₹491.74 crore, and turnover growth slowed to near-flat 1.9% in FY25. This is a high-price acquisition for a thinly profitable subsidiary.
- Indo-National ↓ (BULLISH)▲
Acquiring additional 1.18% in Medcuore Medical Solutions for ₹74.9 lakh (₹16,536/share), raising stake to 60.34%. Medcuore's FY26 turnover surged 311% YoY to ₹1.46 crore from ₹0.35 crore, though FY25 had declined from FY24. The sharp recovery signals strong demand for air monitoring systems.
- Tierra Agrotech ↓ (NEUTRAL)▲
Received BSE observation letter for composite scheme with Nishpra Community Solutions, moving closer to completion. No financial details disclosed, but regulatory progress is a positive step.
- RDB Real Estate ↓ (NEUTRAL)▲
Investing ₹49,000 for 49% in SPV for Gems & Jewellery Park in Raipur under PPP mode. Minimal capital outlay but high strategic value; no financial data available.
- Deep Diamond India ↓ (BEARISH)▲
Disclosed delayed advance payment of ₹2.85 crore for land in Pune for a naturopathy centre. The company is pivoting from diamonds to health/wellness, but the disclosure delay raises governance concerns.
Risk Flags (8)
- Emcure Pharmaceuticals / Overvaluation Risk↓ [HIGH RISK]▼
Acquiring 12.05% of Gennova for ₹231.87 crore implies a 100% valuation of ~₹1,924 crore, while Gennova's FY26 PAT was only ₹5.43 crore (PAT margin ~1.1%). This translates to a P/E of ~354x, extremely high for a subsidiary with slowing revenue growth (1.9% in FY25).
- Somany Ceramics / Execution Risk↓ [MEDIUM RISK]▼
Two of three investments (₹60.80 crore total) are in pre-revenue entities (Siravit Ceramics and V.S. Industries) with no historical turnover. The Siravit investment is a related party transaction, raising governance scrutiny. Failure to achieve commercial milestones could lead to capital erosion.
- Deep Diamond India / Governance Risk↓ [HIGH RISK]▼
Delayed disclosure of a ₹2.85 crore advance payment for land acquisition (MoU dated March 6, 2026, last payment June 6, 2026) due to 'oversight' raises red flags on internal controls and compliance culture.
- Grasim Industries / Integration Risk↓ [MEDIUM RISK]▼
The INR 17,200 crore acquisition of SPPL's 5.0 GWp portfolio requires regulatory approvals (CCI, CTU) and successful integration with ABReN's existing 4.4 GWp. Any delays beyond the December 31, 2026 target could impact projected synergies.
- Tata Capital / Regulatory Risk↓ [MEDIUM RISK]▼
The Yogakshemam acquisition requires RBI approval, and the gold loan segment is subject to regulatory changes (e.g., LTV ratios, KYC norms). Any adverse regulatory action could impact the ₹708 crore AUM and growth plans.
- Creative Newtech / Valuation Risk↓ [MEDIUM RISK]▼
The USD 4M budget for 100% of Infinova India is subject to due diligence and closing adjustments. If Infinova's financials are weak, the final price may still be high relative to earnings. No revenue/profit data provided for Infinova.
-
The amalgamation (share ratio 10:36) involves two companies with no disclosed financial performance. Shareholders of India Radiators face dilution, and the combined entity's prospects are unclear.
- Aster DM Healthcare / Dilution Risk↓ [MEDIUM RISK]▼
Post-amalgamation, issued capital increased from 51.8 crore to 87.2 crore shares (68% dilution). While the merger creates scale, existing shareholders' stakes are significantly diluted.
Opportunities (8)
- Grasim Industries / Renewable Energy Scale↓ (OPPORTUNITY)◆
The acquisition of SPPL's 5.0 GWp portfolio (3.3 GWp operational) at an EV of INR 17,200 crore (~₹3.44 crore/MW) is competitively priced compared to recent renewable asset transactions. Combined with ABReN's existing 4.4 GWp, the entity becomes a top-5 Indian renewable player. Investors can play the green energy megatrend through Grasim's stock.
- Tata Capital / Gold Loan Entry↓ (OPPORTUNITY)◆
Acquiring Yogakshemam Loans at ≤₹318 crore pre-money valuation for 88.6% stake implies an EV of ~₹359 crore for a company with ₹708 crore AUM (EV/AUM ~0.5x). This is attractive compared to listed gold loan NBFCs trading at 2-3x AUM. TCL's AAA rating can lower Yogloans' funding costs, boosting margins.
- Indo-National / Medcuore Growth↓ (OPPORTUNITY)◆
Medcuore's FY26 turnover surged 311% YoY to ₹1.46 crore, recovering from a FY25 dip. Indo-National's increasing stake to 60.34% at ₹16,536/share provides exposure to the high-growth air monitoring and purification segment.
- Creative Newtech / Make in India Play↓ (OPPORTUNITY)◆
Acquiring Infinova's Pune manufacturing facility and exclusive brand rights for up to USD 4M enables a shift from distribution to manufacturing. The surveillance technology market in India is growing at 15-20% CAGR, and this acquisition provides a ready platform.
- Somany Ceramics / Southern Market Expansion↓ (OPPORTUNITY)◆
Investment in Siravit Ceramics (49% stake) targets the fast-growing Southern glazed vitrified tiles market. With Somany's distribution network, Siravit can achieve faster ramp-up. The ₹58.80 crore investment is modest relative to Somany's market cap.
- Aster DM Healthcare / Post-Merger Synergies↓ (OPPORTUNITY)◆
The completed amalgamation with Quality Care India creates a larger hospital chain with potential cost synergies in procurement, IT, and back-office. The combined entity can negotiate better rates with insurers and suppliers.
- Tierra Agrotech / Scheme Progress↓ (OPPORTUNITY)◆
Receipt of BSE observation letter for composite scheme with Nishpra Community Solutions is a positive regulatory milestone. If the scheme is value-accretive, it could unlock shareholder value.
- RDB Real Estate / PPP Infrastructure Play↓ (OPPORTUNITY)◆
The 49% stake in the Gems & Jewellery Park SPV under PPP mode in Raipur provides exposure to government-backed infrastructure development with minimal upfront capital (₹49,000).
Sector Themes (6)
- Renewable Energy Consolidation◆
Grasim's INR 17,200 crore acquisition of a 5.0 GWp portfolio from Shell marks a major consolidation in Indian renewables. The deal combines SPPL's 3.3 GWp operational assets with ABReN's 4.4 GWp, creating a ~9.4 GWp platform. This reflects a trend of large conglomerates (Aditya Birla, Reliance, Tata) aggregating renewable assets to achieve scale and cost advantages.
- NBFC Gold Loan Expansion◆
Tata Capital's entry into gold loans via acquisition (Yogakshemam Loans) mirrors a broader trend of large NBFCs and banks acquiring regional gold loan players to capture market share in this high-margin, secured lending segment. With AUM of ₹708 crore and 162 branches, this provides an immediate foothold in four southern states.
- Healthcare Consolidation via Amalgamation◆
The Aster DM-Quality Care merger (completed) and the India Radiators-Mercantile Ventures amalgamation highlight ongoing consolidation in healthcare and related sectors. These schemes create larger entities with improved bargaining power and operational efficiencies.
- Make in India / Manufacturing Shift◆
Creative Newtech's acquisition of Infinova's Pune manufacturing facility and Somany Ceramics' investment in a new ceramic tiles venture (Siravit) underscore a strategic shift toward domestic manufacturing. Companies are leveraging the government's production-linked incentive (PLI) schemes and import substitution opportunities.
- Pre-Revenue Venture Risk◆
Multiple filings involve investments in pre-revenue or early-stage entities (Somany's Siravit Ceramics and V.S. Industries, Deep Diamond's land for naturopathy centre). While these offer high upside, they carry significant execution risk and require close monitoring of milestone achievement.
- Cross-Border M&A Activity◆
The Grasim-Shell (India-Mauritius) and Creative Newtech-Infinova (India-India but with global brand rights) deals indicate cross-border M&A is active. Indian companies are acquiring both domestic assets from foreign sellers and international brand rights to strengthen their product portfolios.
Watch List (8)
-
The SPPL acquisition requires Competition Commission of India and Central Transmission Utility approvals. Any delays or conditions could impact the December 31, 2026 completion target. Watch for regulatory filings and updates.
-
The acquisition is subject to RBI approval, expected within 8 months. Any regulatory pushback on the valuation or structure could delay or alter the deal. Watch for RBI communication.
-
The acquisition of remaining 12.05% stake (closing by July 31, 2026) at a high valuation (P/E ~354x) needs monitoring. Watch for Gennova's future revenue and profit trends to justify the price.
-
With the amalgamation completed, watch for the combined entity's first quarterly results to assess revenue synergies, cost savings, and margin improvement.
-
The pre-revenue venture targeting Southern markets needs to achieve commercial production milestones. Watch for announcements on plant commissioning and initial orders.
-
The final consideration is subject to due diligence and closing adjustments. Watch for definitive agreement details and any changes to the USD 4M budget.
-
The delayed disclosure of a ₹2.85 crore advance payment raises governance concerns. Watch for any further compliance lapses or regulatory action by BSE/NSE.
-
The record date for share exchange is July 24, 2026. Shareholders of India Radiators should ensure their holdings are updated. Post-amalgamation, watch for the combined entity's financial disclosures.
Filing Analyses
(15)
13-07-2026
Aster DM Quality Care Limited (formerly Aster DM Healthcare Ltd.) has completed the allotment of 35,35,51,410 equity shares to shareholders of Quality Care India Limited under a Scheme of Amalgamation approved by the NCLT. The share exchange ratio was 977 shares of Aster for every 1,000 shares of Quality Care. Post-allotment, the company's issued equity capital increased from INR 5,18,12,10,290 (51,81,21,029 shares) to INR 8,71,67,24,390 (87,16,72,439 shares).
- · The share exchange ratio was 977 equity shares of Aster for every 1,000 equity shares of Quality Care India Limited.
- · The NCLT Hyderabad Bench approved the scheme on 19 June 2026.
- · The allotted shares rank pari passu with existing shares and will be listed on BSE and NSE.
- · The company has changed its name to Aster DM Quality Care Limited.
13-07-2026
Emcure Pharmaceuticals has executed Share Transfer Agreements to acquire the remaining 12.05% stake in its subsidiary Gennova Biopharmaceuticals for an aggregate cash consideration of ₹2,318.7 Million, making Gennova a wholly-owned subsidiary. Gennova reported a turnover of ₹4,917.42 Million for FY26 with a PAT of only ₹54.25 Million, indicating thin profitability. The acquisition is expected to close by July 31, 2026.
- · Gennova's PAT for FY26 was only ₹54.25 Million on turnover of ₹4,917.42 Million, implying a net profit margin of ~1.1%.
- · The acquisition consideration of ₹2,318.7 Million for a 12.05% stake values 100% of Gennova at approximately ₹19,240 Million (₹2,318.7M / 12.05%).
- · Gennova's turnover growth slowed sharply from 14.4% in FY26 to just 1.9% in FY25, indicating near-flat performance in the prior year.
- · The transaction involves related parties as a Promoter/Director of Emcure is also a Director of Gennova, but is stated to be at arm's length.
- · Completion is expected on or before July 31, 2026.
13-07-2026
India Radiators Ltd (Transferor Company) has received NCLT approval for its amalgamation with Mercantile Ventures Ltd (Transferee Company). The Board approved a share exchange ratio of 10 equity shares of the transferee for every 36 shares of the transferor, with a record date of July 24, 2026, and an appointed date of January 1, 2025. The scheme will become effective upon filing the NCLT order with the Registrar of Companies.
- · NCLT order dated July 8, 2026, sanctioned the amalgamation scheme.
- · Record date for determining shareholders entitled to transferee shares is July 24, 2026.
- · Appointed date for the amalgamation is January 1, 2025.
- · Effective date will be communicated after filing the NCLT order with the Registrar of Companies.
13-07-2026
Mercantile Ventures Limited (Transferee) has received NCLT approval for the Scheme of Amalgamation with India Radiators Limited (Transferor), with an appointed date of January 1, 2025. Under the share exchange ratio, shareholders of India Radiators will receive 10 equity shares of Mercantile Ventures for every 36 shares held. The record date for determining eligible shareholders is July 24, 2026, and the scheme will become effective upon filing the NCLT order with the Registrar of Companies.
- · Face value of both companies' equity shares is INR 10 each fully paid up.
- · NCLT order was dated July 8, 2026, from Division Bench - I, Chennai.
- · Appointed date for the amalgamation is January 1, 2025.
- · The effective date will be communicated after filing the NCLT order with the Registrar of Companies, Chennai.
13-07-2026
Mercantile Ventures Limited has set a record date of July 24, 2026, to determine the shareholders of India Radiators Limited (Transferor Company) who will receive equity shares of Mercantile Ventures under a scheme of amalgamation. The share exchange ratio is 10 equity shares of Mercantile Ventures (face value ₹10 each) for every 36 equity shares of India Radiators (face value ₹10 each).
- · Record date is Friday, July 24, 2026.
- · The scheme involves the amalgamation of India Radiators Limited (Transferor Company) into Mercantile Ventures Limited (Transferee Company).
- · Share exchange ratio: 10 equity shares of Mercantile Ventures (₹10 face value) for every 36 equity shares of India Radiators (₹10 face value).
- · The filing is made under Regulation 42 of SEBI LODR.
13-07-2026
India Radiators Ltd (Transferor Company) has set a record date of July 24, 2026, for its shareholders to receive equity shares of Mercantile Ventures Ltd (Transferee Company) under a Scheme of Amalgamation. The share exchange ratio is 10 equity shares of the transferee company (face value ₹10 each) for every 36 equity shares of the transferor company (face value ₹10 each). This is a purely procedural disclosure; no financial performance data is provided.
- · Record date: Friday, July 24, 2026
- · Share exchange ratio: 10 equity shares of Mercantile Ventures Ltd for every 36 equity shares of India Radiators Ltd
- · Scrip code: 505100, Symbol: INRADIA
- · Book closure: Not applicable
13-07-2026
Indo-National Limited has acquired an additional 1.18% equity stake in Medcuore Medical Solutions Private Ltd (MMSPL) for ₹74,90,808, increasing its aggregate shareholding to 60.34%. The acquisition is a cash transaction at ₹16,536 per share, aimed at facilitating business growth and revenue expansion. MMSPL, which manufactures air monitoring systems and air purifiers, reported a sharp increase in turnover to ₹1,45,60,000 in FY26 from ₹35,41,484 in FY25, though its FY24 turnover was ₹47,68,000, indicating a decline from FY24 to FY25 before the recent surge.
- · The acquisition is not a related party transaction; no promoter/promoter group/group companies have interest in MMSPL.
- · MMSPL was incorporated on June 7, 2020.
- · The indicative completion timeframe for the acquisition is up to FY 2027-28.
- · No governmental or regulatory approvals are required for the acquisition.
- · MMSPL's turnover declined from ₹47,68,000 in FY24 to ₹35,41,484 in FY25 before surging to ₹1,45,60,000 in FY26.
13-07-2026
RDB Real Estate Constructions Limited has approved a 49% investment in a new Special Purpose Vehicle (SPV) named ASHOKA - RDB INFRASTRUCTURE & DEVELOPMENT PRIVATE LIMITED, to be incorporated for developing a Gems & Jewellery Park under PPP mode in Raipur, Chhattisgarh. The investment is a cash consideration of ₹49,000 for 4,900 equity shares of ₹10 each. The filing does not provide any financial performance data or period-over-period comparisons, as it is a forward-looking incorporation announcement.
- · The SPV is being incorporated in India and belongs to the Real Estate industry.
- · Ashoka Buildcon Limited is the holding company of the incorporated entity, with no relation to the listed entity.
- · No governmental or regulatory approvals are required for the incorporation.
- · The consideration is in cash, not share swap.
13-07-2026
Tierra Agrotech Limited (TAL) has received an observation letter from BSE Limited regarding its composite scheme of arrangement with Nishpra Community Solutions Private Limited (NSPL). The scheme, approved by TAL's board in January 2026, is now one step closer to completion after BSE's review. No financial details or specific conditions of the observation letter were disclosed.
- · The scheme was initially approved by TAL's board on January 12, 2026.
- · The application to BSE was filed on January 13, 2026.
- · The observation letter was received on July 13, 2026.
- · The scheme is under Sections 230 to 232 of the Companies Act, 2013.
13-07-2026
Grasim Industries' subsidiary Aditya Birla Renewables Limited (ABReN) has approved the acquisition of 100% of Solenergi Power Private Limited (SPPL) from Shell Overseas Investment B.V. for an enterprise value of INR 17,200 crore (~$1.8 billion). SPPL holds a contracted renewable energy portfolio of ~5.0 GWp (3.3 GWp operational, 1.7 GWp under construction) and reported consolidated turnover of INR 1,253.4 crore in FY25, up from INR 1,158.1 crore in FY24 (8.2% growth) and INR 1,156.5 crore in FY23 (0.1% growth). The acquisition significantly accelerates ABReN's renewable energy growth strategy by combining its existing ~4.4 GWp portfolio with SPPL's complementary platform, though it remains subject to regulatory approvals from the Competition Commission of India and Central Transmission Utility, with completion targeted by December 31, 2026.
- · SPPL was incorporated in Mauritius in September 2016 and functions as an investment holding company for Sprng Energy Private Limited and Sprng Solar Plus Private Limited.
- · The acquisition is not a related party transaction; neither the seller nor SPPL are related parties of Grasim.
- · Regulatory approvals required: Competition Commission of India and Central Transmission Utility of India Limited.
- · The aggregate equity consideration payable to the seller will be determined after adjustments for debt, cash, and other items as detailed in the SPA.
- · The transaction does not affect the payment of interest or principal on listed non-convertible debt securities of ABReN.
13-07-2026
Deep Health AI India Limited (formerly Deep Diamond India Limited) disclosed a proposed acquisition of land in Pune district for a naturopathy and holistic rejuvenation centre, for which it has made an aggregate advance payment of ₹2,85,00,000. The disclosure was delayed due to an oversight, and the company has now reported it to the exchange. No financial performance data is available in this filing.
- · The MoU for the land acquisition was dated March 06, 2026.
- · The last tranche of the advance payment was made on June 06, 2026.
- · The land is located at Gat No. 358, Village Mouje Kashal, Taluka – Maval, District Pune – 412106, Maharashtra, India.
- · The company's name was changed from Deep Diamond India Limited to Deep Health AI India Limited.
13-07-2026
Tata Capital Limited (TCL) has approved the acquisition of approximately 88.6% of Yogakshemam Loans Limited (Yogloans), an RBI-registered NBFC primarily engaged in gold loans, for a pre-money equity valuation not exceeding ₹318 crore. The all-cash transaction includes a primary capital infusion of approximately ₹93 crore and marks TCL's entry into the gold loan segment. Yogloans reported a turnover of ₹14,038.53 Lakhs (₹140.39 crore) and profit after tax of ₹1,421.20 Lakhs (₹14.21 crore) for FY 2025-26, with AUM of ₹708 crore as of March 31, 2026. The acquisition is expected to close within 8 months, subject to RBI approval and customary conditions.
- · Yogloans was incorporated on February 13, 1991 and is headquartered in Thrissur, Kerala.
- · Yogloans holds a CRISIL rating of BBB-.
- · Tata Capital is rated AAA with stable outlook by CRISIL, ICRA, CARE and India Ratings, and has an international rating of BBB (Stable) by S&P and Fitch.
- · Tata Capital is classified as an Upper Layer NBFC under RBI's Scale Based Regulatory Framework.
- · The acquisition is not a related party transaction and the promoter/promoter group has no interest in Yogloans.
- · Post-acquisition, Mr. Unnikrishnan will continue to lead Yogloans.
- · Tata Capital intends to consolidate Yogloans at an appropriate stage, subject to approvals.
- · Yogloans operates across Karnataka (54 branches), Kerala (65), Tamil Nadu (25) and Andhra Pradesh (18).
- · The transaction is subject to prior approval of the Reserve Bank of India.
13-07-2026
Tata Capital Limited (TCL) has approved the acquisition of approximately 88.6% of Yogakshemam Loans Limited (Yogloans), an RBI-registered NBFC primarily engaged in gold loans, for a pre-money equity valuation not exceeding ₹318 crore, including a primary capital infusion of approximately ₹93 crore. The all-cash transaction marks TCL's entry into the gold loan segment, providing an established platform with ₹708 crore AUM, 162 branches, and ~32,000 customers across four southern states. While the acquisition diversifies TCL's retail lending portfolio and offers growth potential, it is subject to regulatory approvals and customary conditions, with completion expected within 8 months.
- · Yogloans was incorporated on February 13, 1991, and is headquartered in Thrissur, Kerala.
- · Yogloans holds a CRISIL rating of BBB-.
- · Tata Capital is rated 'AAA with stable outlook' by CRISIL, ICRA, CARE, and India Ratings, and has an international rating of BBB (Stable) by S&P and Fitch.
- · Tata Capital's distribution network spans 1,477 branches across 27 states and union territories as of March 31, 2026.
- · The acquisition is subject to prior approval from the Reserve Bank of India and is expected to close within 8 months from July 13, 2026.
- · Yogloans also offers vehicle loans, business loans, consumer durable loans, term loans, and microfinance loans in addition to gold loans.
- · The consideration for the share purchase from sellers will be based on Yogloans' net worth as of September 30, 2026.
13-07-2026
Creative Newtech Ltd's Board approved the acquisition of 100% of Infinova (India) Private Limited for a budget of up to USD 4.00 Million. The deal includes Infinova's Indian operations, exclusive brand rights, technical assistance, its experienced team, and a Pune-based assembly and manufacturing facility. This acquisition supports Creative Newtech's strategic shift from a distribution-led model to an integrated surveillance technology platform, aligning with its Make in India initiative.
- · The acquisition is not a related-party transaction; promoters and group companies have no interest in Infinova India except in relation to the proposed transaction.
- · Infinova India was incorporated in 2010 and operates an assembly and manufacturing facility in Pune.
- · The final consideration is subject to due diligence, valuation reports, closing adjustments of working capital, and execution of definitive agreements.
- · The exact completion timeline will be disclosed upon execution of definitive agreements.
- · The consideration will be paid in cash.
13-07-2026
Somany Ceramics Limited's board approved three investment proposals totaling up to ₹75.80 crore: a ₹58.80 crore investment for up to 49% in Siravit Ceramics (a pre-revenue glazed vitrified tiles venture targeting the Southern market), a ₹2.00 crore investment for up to 50% in V.S. Industries (a newly incorporated Nepal-based construction chemicals JV), and a ₹15.00 crore additional investment in its subsidiary Sudha Somany Ceramics for plant modernization. While the subsidiary investment supports an existing profitable operation (FY26 turnover ₹24,306.87 lakh, up 5.5% YoY), the two new ventures are in pre-revenue entities with no historical turnover, carrying execution and market risks.
- · Siravit Ceramics has authorised share capital of ₹14,00,00,000 and paid-up capital of ₹8,60,00,000; it has not commenced commercial operations and turnover is nil.
- · V.S. Industries was incorporated on 27 April 2026 in Nepal with authorised capital of NPR 10,00,00,000 and paid-up capital of NPR 50,00,000; it has no turnover.
- · The Siravit Ceramics investment is a related party transaction under SEBI LODR, but the target is not a related party; promoters have no interest in it.
- · The V.S. Industries investment is not a related party transaction.
- · The SSCPL investment is a related party transaction (subsidiary) and will be at arm's length.
- · Completion timeline: Siravit Ceramics ~90 days; V.S. Industries ~120 days subject to regulatory approvals; SSCPL within statutory time limits.
Get daily alerts with 10 investment signals, 8 risk alerts, 8 opportunities and full AI analysis of all 15 filings
₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: India Sector Consolidation Regulatory Filings
July 05, 2026
India Sector Consolidation Regulatory Filings — July 05, 2026
July 04, 2026
India Sector Consolidation Regulatory Filings — July 04, 2026
July 03, 2026
India Sector Consolidation Regulatory Filings — July 03, 2026
July 02, 2026
India Sector Consolidation Regulatory Filings — July 02, 2026
🇮🇳 More from India
View all →July 06, 2026
India Pre-Market Regulatory Roundup — July 06, 2026
India Pre-Market Regulatory Roundup
July 06, 2026
India Quarterly Results BSE NSE Announcements — July 06, 2026
India Quarterly Results BSE NSE Announcements
July 06, 2026
India Upcoming Corporate Actions BSE NSE — July 06, 2026
India Upcoming Corporate Actions BSE NSE
July 06, 2026
BSE Pharma Sector Regulatory Filings — July 06, 2026
BSE Pharma Sector Regulatory Filings